{"date":"2026-04-10","count":31,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6469-2026-04-10-1827-3l7cqs","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-04-10","time":"18:27:27","subject":"更正本公司114年度個體財務報告附註揭露","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-04-10 18:27，「更正本公司114年度個體財務報告附註揭露」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-10-1809-5flzk1","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"18:09:14","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-10 18:09，「公告本公司董事會決議召開115年股東常會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-04-10-1803-1utl0ou","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"18:03:46","subject":"本公司董事會決議發行限制員工權利新股","clause":"第11款","fact_date":"2026-04-10","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-04-10 18:03，「本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-10-1800-1ol3y2x","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"18:00:12","subject":"公告本公司股票初次上市現金增資委託代收及存儲價款機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-10 18:00，「公告本公司股票初次上市現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-10-1800-10apgwn","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"18:00:05","subject":"公告本公司股票初次上市前現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-10 18:00，「公告本公司股票初次上市前現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-04-10-1755-1qb15ta","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-10","time":"17:55:54","subject":"公告本公司取得經濟部產業發展署出具之「係屬科技事業及產品開發成功且具市場性」之意見書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-04-10 17:55，「公告本公司取得經濟部產業發展署出具之「係屬科技事業及產品開發成功且具市場性」之意見書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-04-10-1750-h0jask","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:50:18","subject":"公告本公司董事會決議通過對子公司源華智醫股份有限公司得分次辦理對該子公司釋股作業","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-04-10 17:50，「公告本公司董事會決議通過對子公司源華智醫股份有限公司得分次辦理對該子公司釋股作業」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-04-10-1749-py1hgd","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:49:08","subject":"公告本公司董事會決議114年股東常會通過私募普通股案，未辦理之額度於115年股東常會後不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-04-10 17:49，「公告本公司董事會決議114年股東常會通過私募普通股案，未辦理之額度於115年股東常會後不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-10-1748-r7qijr","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:48:45","subject":"公告本公司董事會決議發行115年度限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-10 17:48，「公告本公司董事會決議發行115年度限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-04-10-1748-1v08jg1","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:48:31","subject":"公告本公司董事會決議辦理私募發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-04-10 17:48，「公告本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-04-10-1747-194xncp","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:47:37","subject":"公告本公司董事會決議召開115年股東常會相關事宜-新增議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-04-10 17:47，「公告本公司董事會決議召開115年股東常會相關事宜-新增議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-04-10-1733-mv63dx","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:33:54","subject":"本公司” HYADERMIS”及” FACILLE”皮下填補劑通過歐盟醫療器材法規MDR審查","clause":"第51款","fact_date":"2026-04-10","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-04-10 17:33，「本公司” HYADERMIS”及” FACILLE”皮下填補劑通過歐盟醫療器材法規MDR審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-10-1728-zgjd9c","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:28:07","subject":"公告本公司董事會決議修訂113及114年度限制員工權利新股發行辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-10 17:28，「公告本公司董事會決議修訂113及114年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-04-10-1719-hk2f6k","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-10","time":"17:19:21","subject":"公告本公司買回庫藏股執行完畢","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-04-10 17:19，「公告本公司買回庫藏股執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-10-1712-qkrt5g","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"17:12:56","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-10 17:12，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-04-10-1650-3sk96k","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-04-10","time":"16:50:03","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-04-10 16:50，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-04-10-1649-15w1hx6","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-04-10","time":"16:49:37","subject":"公告本公司董事會決議召開115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-04-10 16:49，「公告本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-10-1647-haitvt","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"16:47:21","subject":"公告本公司董事會決議115年第1季不辦理虧損撥補暨115年第1季不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-10 16:47，「公告本公司董事會決議115年第1季不辦理虧損撥補暨115年第1季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-04-10-1614-15xw8x1","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-10","time":"16:14:03","subject":"本公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之規定辦理公告","clause":"第20款","fact_date":"2026-04-10","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-04-10 16:14，「本公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-04-10-1604-bwopfv","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-10","time":"16:04:10","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-04-10","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-04-10 16:04，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-04-10-1603-drgvb6","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-10","time":"16:03:03","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-04-10","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-04-10 16:03，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-10-1545-9h0ctm","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"15:45:23","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-10 15:45，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-04-10-1538-1nb8hvk","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-04-10","time":"15:38:56","subject":"公告本公司董事會決議通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-10","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-04-10 15:38，「公告本公司董事會決議通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-04-10-1538-1jhewlf","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"15:38:04","subject":"公告本公司公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-04-10 15:38，「公告本公司公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-04-10-1512-xev7kf","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"15:12:02","subject":"公告本公司取得會計師114年內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-04-10 15:12，「公告本公司取得會計師114年內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-04-10-1459-nuwj18","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-04-10","time":"14:59:51","subject":"本公司受邀參加由寬量國際主辦之「19th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-04-10 14:59，「本公司受邀參加由寬量國際主辦之「19th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-10-1431-8www2v","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"14:31:29","subject":"本公司受邀參加寬量國際主辦之「19th QIC CEO Week」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-10 14:31，「本公司受邀參加寬量國際主辦之「19th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-04-10-1430-16ed061","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"14:30:18","subject":"本公司與長庚醫療財團法人林口長庚紀念醫院簽署硼中子捕獲治療（BNCT）應用於乳癌臨床試驗計畫合作意向書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-04-10 14:30，「本公司與長庚醫療財團法人林口長庚紀念醫院簽署硼中子捕獲治療（BNCT）應用於乳癌臨床試驗計畫合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-04-10-1418-ois9r3","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-04-10","time":"14:18:22","subject":"公告本公司初次申請股票創新板上市時所出具之承諾事項暨其後續執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-04-10 14:18，「公告本公司初次申請股票創新板上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-04-10-1120-1bmtxox","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-04-10","time":"11:20:33","subject":"本公司受邀參加寬量國際主辦之「19th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊","clause":"第12款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-04-10 11:20，「本公司受邀參加寬量國際主辦之「19th QIC CEO Week」，說明本公司之營運概況、財務及業務相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-04-10-1030-11b1948","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-04-10","time":"10:30:12","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-12","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-04-10 10:30，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}